Targeting cancer metabolic vulnerabilities for advanced therapeutic efficacy.

Muluh, Tobias Achu; Shu, Xing-Sheng; Ying, Ying

Muluh, Tobias Achu; Shu, Xing-Sheng; Ying, Ying.

Affiliation

Muluh TA; Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China.
Shu XS; Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China.
Ying Y; Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China; Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China. Electronic address: yingying@szu.edu.cn.

Biomed Pharmacother ; 162: 114658, 2023 Jun.

Article in En | MEDLINE | ID: mdl-37031495

Subject(s)

Neoplasms; Humans; Neoplasms/drug therapy; Energy Metabolism; Glycolysis; Signal Transduction; Tumor Microenvironment

Key words

Cancer metabolism; Lipid metabolism; Metabolic reprogramming and Pathways; Reactive oxygen species; Tumor microenvironment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Biomed Pharmacother Year: 2023 Document type: Article Affiliation country: China Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google